NCT02854059 - IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Purpura, Thrombotic Thrombocytopenic

Interventions

BIOLOGICAL

IdeS (0.25 mg/kg)

Single i.v. infusion of IdeS (0.25 mg/kg). Following an evaluation of efficacy and safety in the first 3 patients the dose may be increased in the following 3 patients to 0.5 mg/kg.

BIOLOGICAL

IdeS (0.50 mg/kg)

Single i.v. infusion of IdeS (0.50 mg/kg).

Trial Locations (1)

NW1 2PG

University College London Hospitals NHS, London